Snapshot Injectable drug delivery is defined as administration of a drug or drugs directly into patientﾒs blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system. Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic. The global Injectable Drug Delivery market size is estimated at xxx million USD with a CAGR xx% from 2017-2022 and is expected to reach xxx Million USD in 2022 with a CAGR xx% from 2022 to 2028. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Injectable Drug Delivery by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Analgesics Antibiotics Immunosuppressive Agents Antihypertensive Agents Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.): Becton Dickinson and Company Baxter International Gerresheimer Pfizer Schott Sandoz Teva Pharmaceutical Industries Eli Lilly and Company Antares Pharma Eli Lilly & Company Hospira Novo Nordik Sanofi Terumo Corporation Unilife Corporation Zogenix Scandinavian Health Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): Aesthetics Autoimmune Diseases Hormonal Disorders Infectious Diseases Oncology Pain Management Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc.) Asia-Pacific (China, India, Japan, Southeast Asia etc.) South America (Brazil, Argentina etc.) Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents 1 Industry Overview 1.1 Injectable Drug Delivery Industry Figure Injectable Drug Delivery Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Injectable Drug Delivery 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Injectable Drug Delivery 1.2.2 Downstream Table Applicatio
